Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank46
3Y CAGR-17.1%
5Y CAGR-20.6%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-17.1%/yr
vs -0.8%/yr prior
5Y CAGR
-20.6%/yr
Recent acceleration
Acceleration
-16.3pp
Decelerating
Percentile
P46
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $212.69M | +1.0% |
| 2024 | $210.65M | -12.5% |
| 2023 | $240.88M | -35.5% |
| 2022 | $373.26M | -21.6% |
| 2021 | $476.15M | -29.2% |
| 2020 | $672.47M | +8.2% |
| 2019 | $621.29M | +61.0% |
| 2018 | $385.88M | +49.6% |
| 2017 | $257.90M | +86.9% |
| 2016 | $138.00M | - |